View in EDS HTML Full Text PDF Full Text

Reversing tozasertib resistance in glioma through inhibition of pyruvate dehydrogenase kinases.

Saved in:
Bibliographic Details
Title: Reversing tozasertib resistance in glioma through inhibition of pyruvate dehydrogenase kinases.
Authors: Jane EP; Department of Neurosurgery, University of Pittsburgh School of Medicine, PA, USA., Premkumar DR; Department of Neurosurgery, University of Pittsburgh School of Medicine, PA, USA.; Department of Neurosurgery, UPMC Hillman Cancer Center, PA, USA., Rajasundaram D; Department of Pediatrics, University of Pittsburgh School of Medicine, PA, USA., Thambireddy S; Department of Neurosurgery, University of Pittsburgh School of Medicine, PA, USA., Reslink MC; Department of Neurosurgery, University of Pittsburgh School of Medicine, PA, USA., Agnihotri S; Department of Neurosurgery, University of Pittsburgh School of Medicine, PA, USA.; Department of Neurosurgery, UPMC Hillman Cancer Center, PA, USA., Pollack IF; Department of Neurosurgery, University of Pittsburgh School of Medicine, PA, USA.; Department of Neurosurgery, UPMC Hillman Cancer Center, PA, USA.
Source: Molecular oncology [Mol Oncol] 2022 Jan; Vol. 16 (1), pp. 219-249. Date of Electronic Publication: 2021 Jun 23.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101308230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0261 (Electronic) Linking ISSN: 15747891 NLM ISO Abbreviation: Mol Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 34058053
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Reversing tozasertib resistance in glioma through inhibition of pyruvate dehydrogenase kinases.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Jane+EP%22">Jane EP</searchLink>; Department of Neurosurgery, University of Pittsburgh School of Medicine, PA, USA.<br /><searchLink fieldCode="AU" term="%22Premkumar+DR%22">Premkumar DR</searchLink>; Department of Neurosurgery, University of Pittsburgh School of Medicine, PA, USA.; Department of Neurosurgery, UPMC Hillman Cancer Center, PA, USA.<br /><searchLink fieldCode="AU" term="%22Rajasundaram+D%22">Rajasundaram D</searchLink>; Department of Pediatrics, University of Pittsburgh School of Medicine, PA, USA.<br /><searchLink fieldCode="AU" term="%22Thambireddy+S%22">Thambireddy S</searchLink>; Department of Neurosurgery, University of Pittsburgh School of Medicine, PA, USA.<br /><searchLink fieldCode="AU" term="%22Reslink+MC%22">Reslink MC</searchLink>; Department of Neurosurgery, University of Pittsburgh School of Medicine, PA, USA.<br /><searchLink fieldCode="AU" term="%22Agnihotri+S%22">Agnihotri S</searchLink>; Department of Neurosurgery, University of Pittsburgh School of Medicine, PA, USA.; Department of Neurosurgery, UPMC Hillman Cancer Center, PA, USA.<br /><searchLink fieldCode="AU" term="%22Pollack+IF%22">Pollack IF</searchLink>; Department of Neurosurgery, University of Pittsburgh School of Medicine, PA, USA.; Department of Neurosurgery, UPMC Hillman Cancer Center, PA, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101308230%22">Molecular oncology</searchLink> [Mol Oncol] 2022 Jan; Vol. 16 (1), pp. 219-249. <i>Date of Electronic Publication: </i>2021 Jun 23.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22John+Wiley+%26+Sons%2C+Inc%22">John Wiley & Sons, Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101308230 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1878-0261 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215747891%22">15747891 </searchLink><i>NLM ISO Abbreviation: </i>Mol Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34058053
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/1878-0261.13025
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 219
    Titles:
      – TitleFull: Reversing tozasertib resistance in glioma through inhibition of pyruvate dehydrogenase kinases.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Jane EP
      – PersonEntity:
          Name:
            NameFull: Premkumar DR
      – PersonEntity:
          Name:
            NameFull: Rajasundaram D
      – PersonEntity:
          Name:
            NameFull: Thambireddy S
      – PersonEntity:
          Name:
            NameFull: Reslink MC
      – PersonEntity:
          Name:
            NameFull: Agnihotri S
      – PersonEntity:
          Name:
            NameFull: Pollack IF
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2022 Jan
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1878-0261
          Numbering:
            – Type: volume
              Value: 16
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Molecular oncology
              Type: main
ResultId 1